전문대학원 소개
한양대학교 의생명공학전문대학원
교직원소개
| 국문 (한자) 성명 | 吳暚翰 | 전공분야 / 연구분야 | 줄기세포신경생물학/줄기세포공학 |
|---|---|---|---|
| 영문성명 | Oh, Yohan | URL | https://sites.google.com/view/yohanslab |
| 현직급 | 교수 | 연구실 전화번호 | 02 - 2220 - 2423 |
| 소속 | 의생명공학전문대학원 의생명과학과 | 학교 이메일 주소 | yoh@hanyang.ac.kr |
경력 및 학위 취득 관련 사항
| 학사학위 취득 관련 사항 | B.S. in Biology (minor in Chemistry). Division of Natural Sciences, College of Science, Yonsei University, Seoul, Korea (2005) |
|---|---|
| 석사학위 취득 관련 사항 | |
| 박사학위 취득 관련 사항 | Ph.D. in Systems Biology. Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea (2012) |
| 주요경력 | 2024.03 - Present: Professor (Lab. of Stem Cell Engineering). Department of Biomedical Science, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Korea |
연구관련자료
| 실험실 명 (국문) | 줄기세포공학 연구실 |
|---|---|
| 실험실 명 (영문) | Lab. of Stem Cell Engineering (SCE) |
| Research interest | My research goal is to develop the extraordinary and biologically feasible model system for answering fundamental questions in human diseases or developmental process, using human pluripotent stem cells. |
| 대표 논문 | Kim, M.S. et al. (Jul. 6,2023) Advanced human iPSC-based preclinical model for Parkinson\\\\\\\'s disease with optogenetic alpha-synuclein aggregation. Cell Stem Cell 30(7): 973-986. |
| 연구 분야 대표 그림 |
|
최근 논문 리스트
13. Oh, Y. (Oct. 26, 2023) Editorial: Cell-based neurodegenerative disease modeling. Front. Cell Dev. Biol. 11: 1323954. IF (JCR_2022) = 5.5
12. Moon, H. et al. (Oct. 11, 2023) Challenges involved in cell therapy for Parkinson’s disease using human pluripotent stem cells. Front. Cell Dev. Biol. 11: 1288168. IF (JCR_2022) = 5.5
11. Kim, M.S. et al. (Jul. 6, 2023) Advanced human iPSC-based preclinical model for Parkinson's disease with optogenetic alpha-synuclein aggregation. Cell Stem Cell 30(7): 973-986. IF (JCR_2022) = 23.9
10. Kim, H. et al. (Aug. 3, 2022) Synthetic peucedanocoumarin IV prevents α-synuclein neurotoxicity in an animal model of Parkinson’s disease. Int. J. Mol. Sci. 23(15): 8618. IF (JCR_2022) = 5.6
9. Jung, Y. et al. (Jul. 13, 2022) Development of a fluorescent nanoprobe based on an amphiphilic single-benzene-based fluorophore for lipid droplets detection and its practical applications. Org. Biomol. Chem. 20(27): 5423-5433. IF (JCR_2022) = 3.2
8. Yoo, H. et al. (Jul. 2022) Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson's disease. BMB Rep. 55(7): 323-335. IF (JCR_2022) = 3.8
7. Lee, H. et al. (Dec. 2021) Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS. Nat. Neurosci. 24(12): 1673-1685. IF (JCR_2021) = 28.771
6. Kim, N.H. et al. (Apr. 1, 2021) AIEgen-based nanoprobe for the ATP sensing and imaging in cancer cells and embryonic stem cells. Anal. Chim. Acta 1152: 338269. IF (JCR_2021) = 6.911
5. Choi, I.Y. et al. (Feb. 2021) Novel culture system via wirelessly controllable optical stimulation of the FGF signaling pathway for human and pig pluripotency. Biomaterials 269: 120222. IF (JCR_2021) = 15.304
4. Kim, N.H. et al. (Apr. 20, 2020) Articulated structures of D-A type dipolar dye with AIEgen: synthesis, photophysical properties, and applications. Materials (Basel) 13(8): E1939. IF (JCR_2020) = 3.623
3. Choi, I.Y. et al. (Feb. 3, 2020) Transcriptional landscape of myogenesis from human pluripotent stem cells reveals a key role of TWIST1 in maintenance of skeletal muscle progenitors. eLife 9: e46981. IF (JCR_2020) = 8.140
2. Mukherjee-Clavin, B. et al. (Jul. 2019) Comparison of three congruent patient-specific cell types for the modelling of a human genetic Schwann-cell disorder. Nat. Biomed. Eng. 3(7): 571-582. IF (JCR_2019) = 18.952
1. Oh, Y. (Jun. 2019) Patient-specific pluripotent stem cell-based Parkinson's disease models showing endogenous alpha-synuclein aggregation. BMB Rep. 52(6): 349-359. IF (JCR_2019) = 3.167
